BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

NIFTY200 Alpha 30

1D
1M
3M
6M
1Y
5Y
empty graph

NIFTY200 Alpha 30 Performance

Day's Range

Low

₹26,298.95

High

₹26,581.35

52 Week Range

Low

₹21,846.40

High

₹27,652.40

Previous Close ₹26,250.70
Day's Range ₹26,298.95 - ₹26,581.35
Open ₹26,339.30
52 Week Range ₹21,846.40 - ₹27,652.40
Volume 40,76,55,048

NIFTY200 Alpha 30 Companies

Company Name LTP (₹) Change (₹) Sector
Bharat Heavy Electricals Ltd. 423.10 Arrow -2.70 (-0.63%) Capital Goods
Steel Authority Of India Ltd. 185.44 Arrow 11.43 (6.57%) Iron & Steel
Vedanta Ltd. 271.00 Arrow 8.00 (3.04%) Non - Ferrous Metals
Hindalco Industries Ltd. 1003.80 Arrow 30.80 (3.17%) Non - Ferrous Metals
The Federal Bank Ltd. 331.30 Arrow 4.30 (1.32%) Bank
Ashok Leyland Ltd. 162.89 Arrow 2.14 (1.33%) Automobile & Ancillaries
Cummins India Ltd. 5010.00 Arrow 47.50 (0.96%) Automobile & Ancillaries
Bharat Forge Ltd. 2004.00 Arrow -5.00 (-0.25%) Automobile & Ancillaries
Eicher Motors Ltd. 7470.00 Arrow 43.00 (0.58%) Automobile & Ancillaries
Shriram Finance Ltd. 1010.80 Arrow 4.80 (0.48%) Finance

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 23446.8 26373.20 22182.55
Nifty IT 28334.05 40301.40 25699.10
Nifty Next 50 72462.4 75000.40 59896.10
NIFTY50 USD Index 8486.15 10443.40 8132.40
Nifty Bank 56548.9 61764.85 49954.85
NIFTY Midcap 100 62396.45 64450.90 52032.85
Nifty 500 22935.1 24144.20 20385.65
Nifty Midcap 50 17979.65 18500.95 14804.55
Nifty 100 24612.25 26975.15 22720.45
Nifty FMCG 46259.35 57445.20 44825.60

Latest News

Sep
23
2026
EQUITY Posted on Sep 23rd 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Pharmaceuticals (Glenmark), a research-led, global pharmaceutical company today announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (U.S. FDA) for its formulations manufacturing facility in Goa, India with a Voluntary Action Indicated (VAI) status. The company has attached media release. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
22
2026
EQUITY Posted on Sep 22nd 2026

Ashok Leyland informs about credit rating

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ashok Leyland has informed that it enclosed the details of Credit Rating received from CARE Ratings. The ratings have been withdrawn for facilities not availed and/or repaid. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Glenmark Pharmaceuticals informs about analyst meet

Pursuant to the Regulation 30 and Para A of Part A of Schedule III of the SEBI LODR, Glenmark Pharmaceuticals has informed that the company will be meeting Investor/Analyst (Participants) in PL Capital - Emerging Titans 2026 Conference on 29-09-2026. No unpublished price sensitive information is proposed to be shared during the meeting. 
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Vedanta informs about disclosure on SAST

Vedanta has informed that it enclosed disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Citicorp International.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
21
2026
EQUITY Posted on Sep 21st 2026

Shriram Finance informs about committee meeting

Shriram Finance has informed that the Banking & Finance Committee today, September 21, 2026 has approved to make a tender offer to purchase for cash up to $300,000,000 of $750,000,000 6.625 per cent. Senior Secured Notes due 2027 and up to $160,000,000 of $500,000,000 6.15 per cent. Senior Secured Notes due 2028 (collectively, the Notes) issued by the Company under the USD 3,500,000,000 Global Medium Term Note Programme (GMTN Programme) of the Company. The Company shall make further intimations in relation to the purchase of the Notes, in accordance with applicable laws. The intimation is being uploaded on the website of the Company at www.shriramfinance.in. 
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of NT200ALP30 index?

The previous close of NT200ALP30 index is ₹26581.35 as of 2026-09-23.

The total volume of NT200ALP30 index is 406660550.00 as of 2026-09-23.

The percentage change in value of NT200ALP30 index is 1.26% as of 2026-09-23.

The absolute increase in NT200ALP30 index value since the previous trading day is ₹330.65 as of 2026-09-23.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore